[HTML][HTML] Physiology of hyperuricemia and urate-lowering treatments
CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …
typically characterized by hyperuricemia and monosodium urate crystal deposition …
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad …
F Sivera, M Andrés, L Carmona, ASR Kydd… - Annals of the …, 2014 - ard.bmj.com
We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …
management of gout. Using a formal voting process, a panel of 78 international …
[PDF][PDF] 2020 American College of Rheumatology guideline for the management of gout
JD FitzGerald, N Dalbeth, T Mikuls… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …
[HTML][HTML] Risk factors and burden of osteoarthritis
C Palazzo, C Nguyen, MM Lefevre-Colau… - Annals of physical and …, 2016 - Elsevier
Osteoarthritis (OA) is one of the most common joint disorders worldwide. Its prevalence is
increasing because of the growing aging of the population in developed and developing …
increasing because of the growing aging of the population in developed and developing …
[HTML][HTML] The British Society for Rheumatology guideline for the management of gout
M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
[PDF][PDF] 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
Objectives To describe trends in the epidemiology of gout and patterns of urate-lowering
treatment (ULT) in the UK general population from 1997 to 2012. Methods We used the …
treatment (ULT) in the UK general population from 1997 to 2012. Methods We used the …
All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study
E Nüesch, P Dieppe, S Reichenbach, S Williams, S Iff… - Bmj, 2011 - bmj.com
Objective To examine all cause and disease specific mortality in patients with osteoarthritis
of the knee or hip. Design Population based cohort study. Setting General practices in the …
of the knee or hip. Design Population based cohort study. Setting General practices in the …
[PDF][PDF] 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis
D Khanna, PP Khanna, JD Fitzgerald… - Arthritis care & …, 2012 - Wiley Online Library
In response to a request for proposal from the American College of Rheumatology (ACR),
our group was charged with developing nonpharmacologic and pharmacologic guidelines …
our group was charged with developing nonpharmacologic and pharmacologic guidelines …
Comorbidities in patients with gout prior to and following diagnosis: case-control study
Objectives To determine the burden of comorbidities in patients with gout at diagnosis and
the risk of developing new comorbidities post diagnosis. Methods There were 39 111 …
the risk of developing new comorbidities post diagnosis. Methods There were 39 111 …